Asset Details
Do you wish to reserve the book?
Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus
Do you wish to request the book?
Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus
2017
Overview
•Pseudorabies virus (PRV) variant strain XJ5 is more virulent than classical strain Ra in 12-week-old pigs.•Bartha-k61 vaccine was effective against both strains mentioned above upon experimental challenge.•Clinical outcome depended on virulence of challenge strains and age of pigs in PRV challenge model.
Since late 2011, pseudorabies (PR) has resurfaced in many large pig farms, causing great economic loss for the swine industry in China. The PRV variant strain with high virulence and antigenic variation has been considered to be the main cause, and much attention has been focused on how to prevent and control the reoccurrence of this disease in China. In this study, two kinds of vaccination strategy were employed to evaluate the protective effects of Bartha-k61vaccine against both variant PRV (XJ5) and classical PRV (Ra) strain challenge. Humoral immunity response, clinical signs, survival rate, body weight, virus shedding and pathology were assessed in commercial pigs. The results showed that Bartha-k61vaccine, administered either once or twice, was effective against the PRV variant (XJ5) challenge, while no significant differences were observed between single and prime-boost vaccinated pigs. However, pigs vaccinated twice had better body weight gains than those vaccinated once, following challenge with the classical PRV strain (Ra) (p<0.01). Therefore, the Bartha-k61 vaccine appears to be an effective vaccine to control the spread of PRV variants in China in the absence of new powerful candidate vaccines specific to these PRV strains.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Animals
/ Antibodies, Viral - biosynthesis
/ China
/ farms
/ Fever
/ Herpesvirus 1, Suid - drug effects
/ Herpesvirus 1, Suid - genetics
/ Herpesvirus 1, Suid - immunology
/ Herpesvirus 1, Suid - pathogenicity
/ Hogs
/ Immunity, Humoral - drug effects
/ Pseudorabies - prevention & control
/ Pseudorabies Vaccines - administration & dosage
/ Survival
/ Swine
/ Vaccines
/ Variant
/ Virus Shedding - drug effects
/ Viruses
